Unhealthy Drug Use in Primary Care Settings
common.study.values.description
“Leveraging Technology to Address Unhealthy Drug Use in Primary Care Settings”
This study will develop a clinical decision support tool that assists primary care providers in carrying out substance use interventions, and then compare (in Phase 2) two clinical scenarios, screening only (SO) vs. SUSIT, (on dose of substance use brief intervention received) and changes in drug use at 3 and 6 months, among primary care patients. Investigators will develop the Clinical Decision Support (CDS) component and then test the full SUSIT approach, using mixed methods to assess its acceptability and adoption, and gathering preliminary data on its efficacy for reducing unhealthy drug use. CDS development is concurrent with the SO phase to avoid losing valuable time, but will be conducted at a secondary study site to avoid contaminating the SO condition.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-no
common.study.methods.is-healthy-no
Screening Only (SO) condition
Patient and PCP are not presented with screening results. The PCP does not receive clinical decision support, or clinical reminders.
SUSIT Condition
Following completion of substance use screening, the tablet computer presents screening results (including level of risk) to the patient for each substance used, asks them to identify their drug of most concern (DOMC), and assesses readiness and confidence to change behavior. Results are delivered to the PCP at the point of care, paired with clinical decision support tailored to the patient's screening results. This information is delivered on the tablet computer, which is handed to the PCP by a ...read more on ClinicalTrials.org
participant.views.study.view.additional
participant.views.study.view.scientific-title
Leveraging Technology to Address Unhealthy Drug Use in Primary Care Settings
common.study.values.clinical-trial-id
NCT02893514
participant.views.study.view.id
Rb4Dxb
